SPECIALIZED PRESS June 23, 2021 Not intended for U.S. and UK MediaVericiguat approved in Japan to treat patients with chronic heart failureRead more
SPECIALIZED PRESS June 21, 2021 Not intended for U.S. and UK MediaBayer submits regulatory applications for oncology treatment combination of copanlisib and rituximab in the U.S. and EURead more
June 8, 2021 Bayer to advance two first-of-its-kind cell and gene therapies for Parkinson’s diseaseRead more
SPECIALIZED PRESS June 3, 2021 Not intended for U.S. and UK MediaBayer acquires Noria and PSMA Therapeutics to expand portfolio in prostate cancerRead more
June 2, 2021 Researchers with unique ideas on helping farmers protect their crops selected as Bayer 2021 Grants4Ag awardeesRead more
May 27, 2021 Leaps by Bayer leads USD 90 Million Series B financing in digital health company Ada HealthRead more
May 27, 2021 Conference Call for investors and mediaAddress by Werner BaumannChairman of the Board of ManagementRead more
May 27, 2021 Bayer announces five-point plan to effectively address potential future Roundup™ claims Read more
May 26, 2021 Senti Bio and BlueRock Therapeutics Enter Collaboration to Develop Gene Circuit-Engineered Cell Therapies for Regenerative MedicineRead more
May 25, 2021 AskBio Announces IND for LION-101, a Novel Investigational AAV Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9), Cleared to Proceed by U.S. FDARead more
